This content is from:Premium Short Sellers Won in Mallinckrodt Mess, but Some Hedgies Held On The specialty pharmaceutical company settled opioid lawsuit and is considering restructuring. ByMichelle Celarier September 10, 2019
This content is from:365亚博 The Morning Brief: Reviled Pharma Exec Martin Shkreli Charged With Hedge Fund Fraud ByStephen Taub December 18, 2015
This content is from:365亚博 The Morning Brief: Marshall Wace Co-Founder Backs Controversial Plan ByAmanda Cantrell September 24, 2015
This content is from:365亚博 Daily Agenda: Yields Rise in U.S. Treasury Markets PBOC suspends renminbi-denominated transactions for a group of foreign banks; biotech company with ties to Shkreli collapses. ByAndrew Barber December 30, 2015
This content is from:365亚博 Drug Wars: The Battle to Put a Lid on Rising Prices In the first of five stories on the battle to address skyrocketing drug prices in the U.S., Institutional Investor looks at how the actions of Turing Pharmaceuticals CEO Martin Shkreli set off a firestorm in Washington. ByKhadijah M. Silver November 25, 2015
